FDA Inspection 1193274 — CSL Plasma Inc.
The FDA completed an inspection of CSL Plasma Inc. on December 15, 2022 in Tulsa, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 15, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tulsa, OK (United States)